We are thrilled to congratulate the JARDIANCE US HCP Marketing Team from Boehringer Ingelheim and Eli Lilly and Company on being selected as an ELITE100 Marketing Team! Don’t miss a chance to meet them and all of our other incredible ELITE winners on June 18th at 230 FIFTH Rooftop in NYC for our celebration of the pharma industry’s best and brightest: https://lnkd.in/g4nE39eW
PM360 Magazine’s Post
More Relevant Posts
-
"Engagement" is a well-known term in marketing, and within the pharmaceutical industry, it assumes a particular form known as HCP (Healthcare Professional) engagement. While you may frequently encounter and use this term, it's crucial to recognize that traditional engagement strategies have become outdated. As the world evolves, so do the methods for capturing the attention of your target audience. Striking the perfect balance is a significant challenge. Many pharmaceutical companies and agencies face substantial obstacles that prevent them from reaching as many potential patients and healthcare professionals (HCPs) as possible. In this post, we will explore the concept of HCP engagement in depth ⬇️ For additional insights, be sure to check the comment section for bonus material created by Viseven CEO Nataliya Andreychuk, featured on pharmaphorum!
-
Buckle up, pharma marketing innovators! The healthcare landscape is evolving at a breakneck speed, and one question echoes in every mind: What trends should pharma marketers be watching in 2024? We've tapped our most visionary leaders at OptimizeRx to share their predictions on the forces driving pharmaceutical marketing in the coming year, starting with our CEO, Will Febbo: "In 2024, I believe HCP marketing will truly become data-driven and clinical in orientation. HCPs have been vocal about their need for less 'spam' and more relevant, value-add brand information for decades. But today, the difference is that pharma can finally connect patient data to drive content relevancy, then deliver that content during specific care decision windows. As a result..." Read more: https://bit.ly/3tRRXgS
-
19th-panel discussion of #GAPSULE is here !! - This is a Dialogue Series, aimed at bridging the knowledge gap between the pharmaceutical industry and medical practitioners for better treatment outcomes. Highlights to be covered during the Webinar: How do brand assets contribute to brand awareness in the pharmaceutical industry? In what ways can brand assets help pharmaceutical companies build emotional connections with their target audience? What lessons can the pharma industry learn from the consumer products and packaged foods industry regarding the effective use of brand assets? How can well-designed brand assets enhance consistency and recognition, ensuring that pharma companies stand out and avoid being mistaken for competitors? How can marketers create brand assets? Watch Mr. Mustufa Arsiwalla, CMO, Britannia Bel Foods, Dr. Sudhakar Gayakwad, Sr. Vice President & Head, McCann Health India and Mr. Vivek Hattangadi, Chief Mentor, The Enablers & PharmaState Academy, join us LIVE for the 19th - panel discussion of #GAPSULE today at 3:00 PM IST Event link: https://lnkd.in/dKgmn8fN
-
Should be very interesting discussion on a very topical subject…
We are excited to announce that Oliver Spray from Protagoras Group will be hosting a webinar with Rachel Kennedy, Chad Schroer, Maja Beilmann-Schramm and Preeti Sule to evaluate the impact of using HCP segmentation methods to customise engagements. Medical Affairs teams within pharmaceutical companies have adopted HCP segmentation methods to drive customisation of external engagements. HCP segmentation allows companies to target specific messages and communication channels based on the HCP’s preferences resulting in an enhanced HCP experience. However, implementing these methods drains company resources including through updating CRM systems, training needs, and consuming MSL time which could otherwise be spent on impactful interactions with HCPs. Indeed, many companies have struggled to show that their investments are having a positive impact on external engagements. This webinar will outline the key segmentation methods Medical Affairs teams are using and address the impact they are having. We will be discussing how pharmaceutical companies can find the right balance between engagement planning and delivery in order to maximise impact. We would like to extend an invitation to our network to attend the webinar, with the opportunity to share your thoughts in the Q&A section. 📆14th September 16:00-17:30 CET 🔗 The webinar will be accessible via Microsoft Teams here: https://lnkd.in/eG5wqucV #Webinar #HCPSegmentation #MedicalAffairs
-
-
Management Consultant Entrepreneur | Organisational Change Enthusiast | Pharma, Tech and Finance
A great topic, and a question that is sometimes ignored in the race to do even more with an ever-expanding tool set. I am a big believer in both increasing capability but also keeping things simple. I look forward to hearing the thoughts of some real practitioners and experts on where this line should be. Maja Beilmann-Schramm, Rachel Kennedy, PhD, Preeti Sule, Chad Schroer and Oliver Spray
We are excited to announce that Oliver Spray from Protagoras Group will be hosting a webinar with Rachel Kennedy, Chad Schroer, Maja Beilmann-Schramm and Preeti Sule to evaluate the impact of using HCP segmentation methods to customise engagements. Medical Affairs teams within pharmaceutical companies have adopted HCP segmentation methods to drive customisation of external engagements. HCP segmentation allows companies to target specific messages and communication channels based on the HCP’s preferences resulting in an enhanced HCP experience. However, implementing these methods drains company resources including through updating CRM systems, training needs, and consuming MSL time which could otherwise be spent on impactful interactions with HCPs. Indeed, many companies have struggled to show that their investments are having a positive impact on external engagements. This webinar will outline the key segmentation methods Medical Affairs teams are using and address the impact they are having. We will be discussing how pharmaceutical companies can find the right balance between engagement planning and delivery in order to maximise impact. We would like to extend an invitation to our network to attend the webinar, with the opportunity to share your thoughts in the Q&A section. 📆14th September 16:00-17:30 CET 🔗 The webinar will be accessible via Microsoft Teams here: https://lnkd.in/eG5wqucV #Webinar #HCPSegmentation #MedicalAffairs
-
-
👩⚕️ Understanding US HCP Perceptions of Pharma Messaging: Explore the latest insights from CMI Media Group’s report on US HCP views of pharma manufacturers and their communication strategies. 🤔 Impact on Pharma Media: What quick pivots can brands action based on these insights on US HCPs? #solli #solliglobal #globalpharmamedia #cmimediagroup #HealthcareMarketing #PharmaInsights #HCP
CMI Media Group: Analyzes US HCP Perceptions of Pharma Messaging
https://solli.global
-
Pharmaceutical marketing is big business and it continues to grow at a rapid rate. In fact, the marketing spend in the pharmaceutical sector has increased by nearly 70% in the past 20 years and now totals nearly $30 billion dollars. The question is whether the current approach to pharma marketing will continue to work in the evolving new world of patient advocacy, preventative care, and strong proof of outcomes demands? We believe the future of pharma marketing looks bright.... #ANPharmaUpdate #ProducedbyANP #Pharmanews #pharmamarketing #pharmanews
The Evolving World of Pharma Marketing
pharmacytimes.com
-
Behavioural Science & Pharmaceutical / Life Science Consultant; Keeping digital health human-centred / TV Guest Expert / Author
FirstWord Pharma spoke with Rashme Cardoza, Global Medical Affairs Consultant, formerly at GSK, about the future of pharma’s advisory boards and how their evolution is driving greater collaboration and innovation within the pharmaceutical industry. A few takeaways: 👩💻 Leveraging technology has revolutionized pharma's approach to seeking expertise and insights, allowing for greater accessibility, diversity, real-world evidence, and patient involvement, whilst being flexible and cost-effective. ⚕ This highlights the growing role of Medical Affairs, with a more strategic contribution to overall business decisions. 📏 Engagement metrics, reach, accessibility and decision impact are key to measuring effectiveness of virtual advisory boards. Read the full report here: https://lnkd.in/esktTKcE It was a pleasure interviewing you, Rashme Cardoza!
ViewPoints: Beyond the boardroom — the rise of virtual and patient-inclusive pharma advisory boards
ml.firstwordpharma.com
-
Positive signs for new medicines this year include revitalised US approvals and thriving innovation. However, our Launch Readiness 2024 guide emphasises that cost and value are critical to launch success. #launchexecution #launchreadiness #SmartLaunch #TRiBECAKnowledge #pharmaceuticalindustry #biotechnologyindustry
Launch Readiness 2024: A fresh look at key trends affecting pharma product launches
tribecaknowledge.com
